RxDoctor Payments Data

Tyler Ball

Neurological Surgery · Nashville, TNNPI 1659799179

Payments from drug & device makers

What this record shows

This record is dominated by grants: $10,000 of the $12,022 with a category attached, or 83.2%. Boston Scientific accounts for 85.2% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2021 at $10,094 and has fallen 96.8% since, to $321 in 2025.

$12,022in general payments, 2019–2025

Across 19 payments — averaging $632.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$10K
  • Medtronic$1K
  • Insightec,inc$284
  • Riwospine, Inc.$216
  • Neuropace, Inc.$43
  • Bioventus LLC$34

What the payments were for

  • Grants$10,00083%
  • Travel & lodging$1,25810%
  • Food & beverage$7646%

General payments by program year

21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific4$10,242
Medtronic9$1,203
Insightec,inc3$284
Riwospine, Inc.1$216
Neuropace, Inc.1$43
Bioventus LLC1$34

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,022 in reported general payments places this provider in the 70th percentile of 156 neurological surgery providers in Tennessee.

See all neurological surgery providers in Tennessee

Medicare billing

Part B allowed, 2024
$103,093
Medicare patients
155
Services billed
326

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Baclofen38$337

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →